Serum sickness-like reaction in a pediatric patient using omalizumab for chronic spontaneous urticaria-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Serum sickness-like reaction in a pediatric patient using omalizumab for chronic spontaneous urticaria

Published:2018-04-15 Issue:4 Volume:29 Page:449-450
ISSN:0905-6157
Container-title:Pediatric Allergy and Immunology
language:en
Short-container-title:Pediatr Allergy Immunol

Author:

Eapen Amy¹^ORCID,Kloepfer Kirsten M.²

Affiliation:

1. Division of Allergy and Immunology; Department of Pediatrics; Cincinnati Children's Hospital Medical Center; Cincinnati OH USA

2. Division of Pulmonary; Department of Pediatrics, Allergy and Sleep Medicine; Indiana University School of Medicine; Indianapolis IN USA

Publisher

Wiley

Subject

Immunology,Immunology and Allergy,Pediatrics, Perinatology and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/pai.12877/fullpdf

Reference12 articles.

1. The EAACI/GA²LEN/EDF/WAO Guideline for the definition, classification, diagnosis and management of Urticaria. The 2013 revision and update;Zuberbier;Allergy,2014

2. Omalizumab for the treatment of chronic spontaneous urticaria: a meta-analysis of randomized clinical trials;Zhao;J Allergy Clin Immunol,2016

3. Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase;Maurer;J Allergy Clin Immunol,2011

4. Hypersensitivity and immunologic reactions to biologics: opportunities for the allergist;Khan;Ann Allergy Asthma Immunol,2016

5. Severe serum sickness-like syndrome after omalizumab therapy for asthma;Pilette;J Allergy Clin Immunol,2007

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hypersensitivity reactions to biologics used in the treatment of allergic diseases: clinical features, diagnosis and management;Frontiers in Allergy;2023-08-11

2. Safety of omalizumab in children;Glavvrač (Chief Medical Officer);2023-07-27

3. Risks and safety of biologics: A practical guide for allergists;World Allergy Organization Journal;2023-01

4. Therapeutical Targets in Allergic Inflammation;Biomedicines;2022-11-09

5. Adverse Reactions to Biologic Medications Used in Allergy and Immunology Diseases;Current Allergy and Asthma Reports;2022-10-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3